[ Price : $8.95]
FDA says healthcare professionals may continue to treat some patients with Iclusig under an emergency IND.[ Price : $8.95]
FDA gives healthcare professionals timing recommendations for placing and removing spinal catheters in patients taking low molecul...[ Price : $8.95]
PhRMA announces a joint program with the Genetic Alliance to use crowd-sourced technology to learn patients experiences with three...[ Price : $8.95]
FDA awards a $4 million contract to RTI International for five studies of various aspects of consumer response to DTC drug ads.[ Price : $8.95]
Federal Register Notice: FDA determines that Moban tablets and capsules were not withdrawn from sale for reasons of safety or effe...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance, Pulmonary Tuberculosis: Developing Drugs For Treatment.[ Price : $8.95]
Federal Register Notice: FDA plans a public meeting 2/7/14 on patient-focused drug development for sickle cell disease.[ Price : $8.95]
Federal Register Notice: FDA announces an opportunity to request a hearing on a proposal to withdraw approval of 14 NDAs.